GSK Tightens Avandia Restrictions

By Derek Hawkins · February 7, 2011, 4:39 PM EST

Under orders from health regulators, GlaxoSmithKline PLC said Monday it had revised safety restrictions on the diabetes drug Avandia because of its links to heart attacks, in a move closely following...

To view the full article, register now.